ICD-10-CM Billable Code

M1A.429

Other secondary chronic gout, unspecified elbow

Clinical Classification Guidelines

Medical Intelligence & Overview

Chronic gout is a form of gout that persists over time, often resulting from long-standing elevated uric acid levels in the blood. When gout affects the elbow, particularly when it becomes a secondary chronic condition, it can cause ongoing discomfort and joint damage. The specific ICD-10 code M1A.429 refers to cases where gout has become a secondary, persistent issue localized to the elbow, but without further detailed specification.

Causes & Symptoms

Clinical Causes: Prolonged high levels of uric acid in the bloodstream (hyperuricemia) Repeated gout attacks leading to chronic joint inflammation Underlying conditions such as kidney disease, obesity, or metabolic syndrome that increase uric acid levels Certain medications that impair uric acid excretion Diet rich in purines, like red meat, seafood, and alcohol, which can elevate uric acid levels Genetic predispositions affecting uric acid metabolism

Key Symptoms: Persistent joint pain and tenderness in the elbow Swelling and redness around the elbow joint Limited range of motion in the affected elbow Presence of tophi (deposits of uric acid crystals) around the joint Repeated episodes of acute gout attacks that may become less severe but persistent Possible formation of joint deformities if left untreated

Diagnostic & Treatment

Diagnosis Path: Diagnosis often involves a combination of clinical evaluation and laboratory tests. Doctors may perform joint examinations to assess swelling and redness. Blood tests measuring uric acid levels can support the diagnosis, although they are not definitive on their own. Synovial fluid analysis via joint aspiration to identify uric acid crystals is the most conclusive method. Imaging studies, such as X-rays or ultrasound, can reveal joint damage, tophi, or calcifications associated with chronic gout.

Treatment Protocols: Managing secondary chronic gout of the elbow aims to reduce uric acid levels and control inflammation. Treatment approaches include: - Prescription medications such as urate-lowering agents (e.g., allopurinol, febuxostat) to prevent crystal formation - Anti-inflammatory drugs to manage pain during flare-ups (e.g., colchicine, NSAIDs, corticosteroids) - Lifestyle modifications including dietary changes to reduce purine intake - Maintaining adequate hydration to facilitate uric acid excretion - Regular monitoring of uric acid levels and kidney function - Physical therapy might be recommended to preserve joint function and mobility Long-term management involves vigilant control of uric acid levels to prevent further joint damage and to reduce the frequency of gout attacks.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M1A.429 a billable ICD-10 code?
Yes, M1A.429 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M1A.429?
Clinical documentation must specify the nature of Other secondary chronic gout, unspecified elbow and any associated comorbidities for accurate reporting.

Cite this Clinical Reference